How can we realize the promise of personalized antidepressant medicines?

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429 · see citing works

Translating the Histone Code

Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · see citing works

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456 · see citing works

Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325 · see citing works

Epigenetic programming by maternal behavior

Weaver, I. C. G., Cervoni, N., Champagne, F. A., D'Alessio, A. C., Sharma, S., Seckl, J. R., Dymov, S., Szyf, M., & Meaney, M. J. (2004) · Nature Neuroscience · doi:10.1038/nn1276 · Cited by 6,177 · see citing works

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project

The ENCODE Project Consortium (2007) · Nature · doi:10.1038/nature05874 · Cited by 5,223 · see citing works

Stress and the brain: from adaptation to disease

de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621 · see citing works

Global variation in copy number in the human genome

Redon, R., Ishikawa, S., Fitch, K. R., Feuk, L., Perry, G. H., Andrews, T. D., Fiegler, H., Shapero, M. H., Carson, A. R., Chen, W., et al. (2006) · Nature · doi:10.1038/nature05329 · Cited by 4,276 · see citing works

Epigenetic differences arise during the lifetime of monozygotic twins

Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602 · see citing works

Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation

Vasudevan, S., Tong, Y., & STEITZ, J. A. (2007) · Science · doi:10.1126/science.1149460 · Cited by 2,806 · see citing works

The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies

Heim, C., & Nemeroff, C. B. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01157-x · Cited by 2,791 · see citing works

Subgenual prefrontal cortex abnormalities in mood disorders

Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693 · see citing works

Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions

Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307 · cited 1× · see citing works

The Corticosteroid Receptor Hypothesis of Depression

Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181 · see citing works

Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action

Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780 · see citing works

New approaches to antidepressant drug discovery: beyond monoamines

Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · see citing works

Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis

Jacobs, L. D., Beck, R. W., Simon, J. H., Kinkel, R. P., Brownscheidle, C. M., Murray, T. J., Simonian, N. A., Slasor, P., & Sandrock, A. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431301 · Cited by 1,498 · see citing works

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485 · see citing works

Epigenetic regulation in psychiatric disorders

Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2132 · Cited by 1,400 · see citing works

Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study

Sheline, Y. I., Barch, D. M., Donnelly, J. M., Ollinger, J. M., Snyder, A. Z., & Mintun, M. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01263-x · Cited by 1,191 · see citing works

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

Binder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977 · see citing works

An optical neural interface: in vivo control of rodent motor cortex with integrated fiberoptic and optogenetic technology

Aravanis, A. M., Wang, L., Zhang, F., Meltzer, L. A., Mogri, M., Schneider, M. B., & Deisseroth, K. A. (2007) · Journal of Neural Engineering · doi:10.1088/1741-2560/4/3/s02 · Cited by 960 · see citing works

Histone methylation in transcriptional control

Kouzarides, T. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00287-3 · Cited by 908 · see citing works

Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life

Weaver, I. C. G., Champagne, F. A., Brown, S. E., Dymov, S., Sharma, S., Meaney, M. J., & Szyf, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3652-05.2005 · Cited by 905 · see citing works

The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesisPreprint

Carmell, M. A., Xuan, Z., Zhang, M. Q., & Hannon, G. J. (2002) · Genes & Development · doi:10.1101/gad.1026102 · Cited by 885 · see citing works

Metabolite profiling: from diagnostics to systems biology

Fernie, A. R., Trethewey, R. N., Krotzky, A. J., & Willmitzer, L. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1451 · Cited by 847 · see citing works

Pharmacogenetics and the practice of medicine

Roses, A. D. (2000) · Nature · doi:10.1038/35015728 · Cited by 803 · see citing works

Towards a theory of biological robustness

Kitano, H. (2007) · Molecular Systems Biology · doi:10.1038/msb4100179 · Cited by 803 · see citing works

Attenuation of the Neural Response to Sad Faces in Major Depressionby Antidepressant Treatment: A Prospective, Event-Related Functional Magnetic Resonance ImagingStudy

Fu, C. H. Y., Williams, S. C. R., Cleare, A. J., Brammer, M. J., Walsh, N. D., Kim, J., Andrew, C. M., Pich, E. M., Williams, P. M., Reed, L. J., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.9.877 · Cited by 775 · see citing works

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

Kirchheiner, J., Nickchen, K., Bauer, M., Wong, M.-L., Licinio, J., Roots, I., & Brockmöller, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001494 · Cited by 727 · see citing works

Increased Numbers of Corticotropin-Releasing Hormone Expressing Neurons in the Hypothalamic Paraventricular Nucleus of Depressed Patients

Raadsheer, F. C., Hoogendijk, W. J. G., Stam, F. C., Tilders, F. J. H., & Swaab, D. F. (2008) · Neuroendocrinology · doi:10.1159/000126778 · Cited by 667 · see citing works

Rad6-Dependent Ubiquitination of Histone H2B in Yeast

Robzyk, K., Recht, J., & Osley, M. A. (2000) · Science · doi:10.1126/science.287.5452.501 · Cited by 666 · see citing works

Psoriasis is associated with increased β-defensin genomic copy number

Hollox, E. J., Hüffmeier, U., Zeeuwen, P. L. J. M., Raquel, P., Lascorz, J., Rodijk‐Olthuis, D., van de Kerkhof, P. C. M., Traupe, H., de Jongh, G. J., den Heijer, M., et al. (2007) · Nature Genetics · doi:10.1038/ng.2007.48 · Cited by 630 · see citing works

SUMO-Specific Protease 1 Is Essential for Stabilization of HIF1α during Hypoxia

Cheng, J., Kang, X., Zhang, S., & Yeh, E. T. H. (2007) · Cell · doi:10.1016/j.cell.2007.08.045 · Cited by 624 · see citing works

Histone Deacetylase 5 Epigenetically Controls Behavioral Adaptations to Chronic Emotional Stimuli

Renthal, W., Maze, I., Krishnan, V., Covington, H. E., Xiao, G., Kumar, A., Russo, S. J., Graham, A., Tsankova, N., Kippin, T. E., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.09.032 · Cited by 599 · see citing works

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients

Serretti, A., Kato, M., De Ronchi, D., & Kinoshita, T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001926 · Cited by 529 · see citing works

Can neuroscience be integrated into the DSM-V?

Hyman, S. E. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2218 · Cited by 516 · see citing works

Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice

Hovatta, I., Tennant, R. S., Helton, R., Marr, R. A., Singer, O., Redwine, J. M., Ellison, J. A., Schadt, E. E., Verma, I. M., Lockhart, D. J., et al. (2005) · Nature · doi:10.1038/nature04250 · Cited by 498 · see citing works

The emerging landscape of breast cancer susceptibility

Stratton, M. R., & Rahman, N. (2008) · Nature Genetics · doi:10.1038/ng.2007.53 · Cited by 487 · see citing works

Variation in the Gene Encoding the Serotonin 2A Receptor Is Associated with Outcome of Antidepressant Treatment

McMahon, F. J., Buervenich, S., Charney, D. S., Lipsky, R. H., Rush, A. J., Wilson, A. F., Sorant, A. J. M., Papanicolaou, G., Laje, G., D, M. F. M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503820 · Cited by 473 · see citing works

High-speed imaging reveals neurophysiological links to behavior in an animal model of depression

Airan, R. D., Meltzer, L. A., Roy, M., Gong, Y., Chen, H., & Deisseroth, K. (2007) · Science · doi:10.1126/science.1144400 · Cited by 396 · see citing works

Polymorphisms in the Drug Transporter Gene ABCB1 Predict Antidepressant Treatment Response in Depression

Uhr, M., Tontsch, A., Namendorf, C., Ripke, S., Lucae, S., Ising, M., Dose, T., Ebinger, M., Rosenhagen, M. C., Kohli, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2007.11.017 · Cited by 381 · see citing works

Combined Dexamethasone/Corticotropin Releasing Hormone Test Predicts Treatment Response in Major Depression–A Potential Biomarker?

Ising, M., Horstmann, S., Kloiber, S., Lucae, S., Binder, E. B., Kern, N., Künzel, H. E., Pfennig, A., Uhr, M., & Holsboer, F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.039 · Cited by 341 · cited 1× · see citing works

RSUME, a Small RWD-Containing Protein, Enhances SUMO Conjugation and Stabilizes HIF-1α during Hypoxia

Carbia-Nagashima, A., Gerez, J., Perez-Castro, C., Paez-Pereda, M., Silberstein, S., Stalla, G. K., Holsboer, F., & Arzt, E. (2007) · Cell · doi:10.1016/j.cell.2007.07.044 · Cited by 318 · see citing works

Molecular studies of major depressive disorder: the epigenetic perspective

Mill, J. S., & Petronis, A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001992 · Cited by 302 · see citing works

Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia

Holmes, E. C., Tsang, T. M., Huang, J. T.-J., Leweke, F. M., Koethe, D., Gerth, C. W., Nolden, B. M., Gross, S., Schreiber, D., Nicholson, J. K., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030327 · Cited by 292 · see citing works

Acetylation and chromosomal functions

Cheung, W. L., Briggs, S. D., & Allis, C. D. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00096-x · Cited by 290 · see citing works

The FKBP5 gene in depression and treatment response – an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) cohort

Lekman, M., Laje, G., Charney, D., Rush, A. J., Wilson, A. F., Sorant, A. J. M., Lipsky, R., Wisniewski, S. R., Manji, H., McMahon, F. J., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.026 · Cited by 284 · see citing works

Effects of the Serotonin Transporter Gene Promoter Polymorphism onMirtazapine and Paroxetine Efficacy and Adverse Events in Geriatric MajorDepression

Murphy, G. M., Hollander, S. B., Rodrigues, H. E., Kremer, C. M. E., & Schatzberg, A. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1163 · Cited by 275 · see citing works

Identification of Glyoxalase-I as a Protein Marker in a Mouse Model of Extremes in Trait Anxiety

Krömer, S. A., Kessler, M. S., Milfay, D., Birg, I., Bunck, M., Czibere, L., Panhuysen, M., Pütz, B., Deussing, J. M., Holsboer, F., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0115-05.2005 · Cited by 263 · see citing works

Metabolomic Mapping of Atypical Antipsychotic Effects in Schizophrenia

Kaddurah-Daouk, R., McEvoy, J., Baillie, R. A., Lee, D., Yao, J. K., Doraiswamy, P. M., & Krishnan, K. R. R. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002000 · Cited by 262 · see citing works

Conserved non-genic sequences — an unexpected feature of mammalian genomes

Dermitzakis, E. T., Reymond, A., & Antonarakis, S. E. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1527 · Cited by 261 · see citing works

The 5-HT transporter gene-linked polymorphic region (5-HTTLPR) in evolutionary perspective: Alternative biallelic variation in rhesus monkeys

Lesch, K., Meyer, J., Glatz, K., Fl�gge, G., Hinney, A., Hebebrand, J., Klauck, S. M., Poustka, A., Poustka, F., Bengel, D., et al. (1997) · Journal of Neural Transmission · doi:10.1007/bf01294726 · Cited by 253 · see citing works

From early to late adulthood changes in EEG sleep of depressed patients and healthy volunteers

Lauer, C. J., Riemann, D. W., Wiegand, M. H., & Berger, M. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90355-p · Cited by 247 · see citing works

Investigation of serotonin-related genes in antidepressant response

Peters, E. J., Slager, S. L., McGrath, P. J., Knowles, J. A., & Hamilton, S. P. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001502 · Cited by 231 · see citing works

From monoamines to genomic targets: a paradigm shift for drug discovery in depression

Wong, M., & Licinio, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1303 · Cited by 225 · see citing works

Megabase deletions of gene deserts result in viable mice

Nóbrega, M. A., Zhu, Y., Plajzer-Frick, I., Afzal, V., & Rubin, E. M. (2004) · Nature · doi:10.1038/nature03022 · Cited by 214 · see citing works

Association of the C(–1019)G 5-HT1A functional promoter polymorphism with antidepressant response

Lemonde, S., Du, L., Bakish, D., Hrdina, P. D., & Albert, P. R. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004699 · Cited by 212 · see citing works

A role for fMRI in optimizing CNS drug development

Borsook, D., Becerra, L. R., & Hargreaves, R. J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2027 · Cited by 203 · see citing works

Evidence for an association between a G-protein β3-gene variant with depression and response to antidepressant treatment

Zill, P., Baghai, T. C., Zwanzger, P., Schüle, C., Minov, C., Riedel, M. J., Neumeier, K., Rupprecht, R., & Bondy, B. (2000) · Neuroreport · doi:10.1097/00001756-200006260-00018 · Cited by 197 · see citing works

Early Changes in Prefrontal Activity Characterize Clinical Responders to Antidepressants

Cook, I. A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00294-4 · Cited by 193 · see citing works

Association of GRIK4 With Outcome of Antidepressant Treatment in the STAR*D Cohort

Paddock, S., Laje, G., Charney, D. S., Rush, A. J., Wilson, A. F., Sorant, A. J. M., Lipsky, R. H., Wisniewski, S. R., Manji, H., & McMahon, F. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111790 · Cited by 192 · see citing works

Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder

Hong, C.-J., Chen, T., Yu, Y. W.-Y., & Tsai, S.-J. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500340 · Cited by 189 · see citing works

Association Study of a Monoamine Oxidase A Gene Promoter Polymorphism with Major Depressive Disorder and Antidepressant Response

Yu, Y. W. ‐., Tsai, S., Hong, C., Chen, T., Chen, M., & Yang, C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300785 · Cited by 183 · see citing works

Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans

Licinio, J., O'Kirwan, F., Irizarry, K. J. L., Merriman, B., Thakur, S., Jepson, R., Lake, S. L., Tantisira, K. G., Weiss, S. T., & Wong, M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001587 · Cited by 168 · see citing works

Association of GRIK4 With Outcome of Antidepressant Treatment in the STAR*D Cohort

Ballenger, J. C. (2009) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)79086-8 · Cited by 167 · see citing works

Genome-based pharmacogenetics and the pharmaceutical industry

Roses, A. D. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd840 · Cited by 167 · see citing works

Blood—Brain Barrier Genomics

Li, J. Y., Boado, R. J., & Pardridge, W. M. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200101000-00008 · Cited by 164 · see citing works

HTR2A Gene Variants and Psychiatric Disorders: A Review of Current Literature and Selection of SNPs for Future Studies

Drago, A., & Ronchi, D. D. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781368450 · Cited by 162 · see citing works

Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients

Hakonarson, H. H., Björnsdóttir, U. S., Halapi, E. C., Bradfield, J. P., Zink, F., Mouy, M., Helgadóttir, H., Gudmundsdottir, A. S., Andrason, H., Adalsteinsdottir, A. E., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409904102 · Cited by 161 · see citing works

Analysis of Association Between the Serotonin Transporter and Antidepressant Response in a Large Clinical Sample

Kraft, J. B., Peters, E. J., Slager, S. L., Jenkins, G. D., Reinalda, M. S., McGrath, P. J., & Hamilton, S. P. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.017 · Cited by 150 · see citing works

The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression

Szegedi, A., Rujescu, D., Tadić, A., Müller, M., Kohnen, R., Stassen, H. H., & Dahmen, N. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500289 · Cited by 149 · see citing works

Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders

Liu, Z., Zhu, F., Wang, G., Xiao, Z., Tang, J., Liu, W., Wang, H., Liu, H., Wang, X., Ying-liang, W., et al. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.013 · Cited by 148 · see citing works

Association Between Treatment-Emergent Suicidal Ideation With Citalopram and Polymorphisms Near Cyclic Adenosine Monophosphate Response Element Binding Protein in the STAR*D Study

Perlis, R. H., Purcell, S., D, M. F. M., Fagerness, J. A., Rush, A. J., Trivedi, M. H., & Smoller, J. W. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.689 · Cited by 148 · see citing works

Association of the COMT val158met Variant with Antidepressant Treatment Response in Major Depression

Baune, B. T., Hohoff, C., Berger, K., Neumann, A., Mortensen, S., Roehrs, T., Deckert, J., Arolt, V., & Domschke, K. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301462 · Cited by 145 · see citing works

Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial

Kagan, B. L., Sultzer, D. L., Rosenlicht, N. Z., & Gerner, R. H. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.5.591 · Cited by 139 · see citing works

Critical Appraisal of DNA Microarrays in Psychiatric Genomics

Mirnics, K., Levitt, P. R., & Lewis, D. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.003 · Cited by 138 · see citing works

MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells

Greco, S. J., & Rameshwar, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703037104 · Cited by 137 · see citing works

The C(–1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings

Serretti, A., Artioli, P., Lorenzi, C., Pirovano, A., Tubazio, V., & Zanardi, R. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004687 · Cited by 131 · see citing works

Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders

Yu, Y. W. ‐., Tsai, S., Liou, Y., Hong, C., & Chen, T. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.12.004 · Cited by 124 · see citing works

Analysis of Association Between the Serotonin Transporter and Antidepressant Response in a Large Clinical Sample

Ballenger, J. C. (2008) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70773-4 · Cited by 123 · see citing works

Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: A pilot study

Bareš, M., Brunovský, M., Kopeček, M., Stopková, P., Novák, T., Kožený, J., & Höschl, C. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.06.005 · Cited by 117 · see citing works

The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments

Serretti, A., Benedetti, F., Zanardi, R., & Smeraldi, E. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.03.013 · Cited by 116 · see citing works

Histone modifications: Now summoning sumoylation

Nathan, D., Sterner, D. E., & Berger, S. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2436173100 · Cited by 116 · see citing works

Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin

Arias, B., Serretti, A., Lorenzi, C., Gastó, C., Catalán, R., & Fañanás, L. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.11.008 · Cited by 112 · see citing works

Association between a G-protein β3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders

Lee, H.-J., Cha, J.-H., Ham, B.-J., Han, C.-S., Kim, Y., Lee, S. H., Ryu, S.-H., Rh, K., Choi, M.-J., & Lee, M.-S. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500217 · Cited by 108 · see citing works

Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway

Matigian, N., Windus, L. C. E., Smith, H., Filippich, C., Pantelis, C., McGrath, J. J., Mowry, B. J., & Hayward, N. K. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001998 · Cited by 106 · see citing works

Serotonin Receptor 2A Gene Polymorphism (–1438A/G) and Short-Term Treatment Response to Citalopram

Choi, M.-J., Kang, R.-H., Ham, B., Jeong, H.-Y., & Lee, M.-S. (2005) · Neuropsychobiology · doi:10.1159/000087847 · Cited by 106 · see citing works

Pharmacogenomics and antidepressant drugs

Binder, E. B., & Holsboer, F. (2006) · Annals of Medicine · doi:10.1080/07853890600551045 · Cited by 100 · see citing works

Electroencephalographic sleep profiles in treatment course and long-term outcome of major depression: association with DEX/CRH-test response

Hatzinger, M., Hemmeter, U., Brand, S., Ising, M., & Holsboer‐Trachsler, E. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.01.010 · Cited by 94 · see citing works

SSRIs antidepressant activity is influenced by Gβ3 variants

Serretti, A. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00154-2 · Cited by 88 · see citing works

Stress-induced changes in primate prefrontal profiles of gene expression

Karssen, A. M., Her, S., Li, J. Z., Patel, P. D., Meng, F., Bunney, W. E., Jones, E. G., Watson, S. J., Akil, H., Myers, R., et al. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002095 · Cited by 82 · see citing works

Protein Biomarkers in a Mouse Model of Extremes in Trait Anxiety

Ditzen, C., Jastorff, A. M., Kessler, M. S., Bunck, M., Teplytska, L., Erhardt, A., Krömer, S. A., Varadarajulu, J., Targosz, B., Sayan-Ayata, E., et al. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600088-mcp200 · Cited by 81 · see citing works

Changes in Brain Function (Quantitative EEG Cordance) During Placebo Lead-In and Treatment Outcomes in Clinical Trials for Major Depression

Hunter, A. M., Leuchter, A. F., Morgan, M. L., & Cook, I. A. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.8.1426 · Cited by 80 · see citing works

The Promise of the Quantitative Electroencephalogram as a Predictor of Antidepressant Treatment Outcomes in Major Depressive Disorder

Hunter, A. M., Cook, I. A., & Leuchter, A. F. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.12.002 · Cited by 78 · see citing works

Association between -1438G/A Promoter Polymorphism in the 5-HT2A Receptor Gene and Fluvoxamine Response in Japanese Patients with Major Depressive Disorder

Sato, K., Yoshida, K., Takahashi, H., Ito, K., Kamata, M., Higuchi, H., Shimizu, T., Itoh, K., Inoue, K., Tezuka, T., et al. (2002) · Neuropsychobiology · doi:10.1159/000066394 · Cited by 77 · see citing works

A splice site polymorphism in the G-protein β subunit influences antidepressant efficacy in depression

Wilkie, M. J. V., Smıth, D. J., Reid, I., Day, R. K., Matthews, K., Wolf, C. R., Blackwood, D., & Smith, G. C. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32801a3be6 · Cited by 76 · see citing works

Polymorphisms in the 5-Hydroxytryptamine 2A Receptor and CytochromeP4502D6 Genes Synergistically Predict Fluvoxamine-Induced Side Effects in Japanese Depressed Patients

Suzuki, Y., Sawamura, K., & Someya, T. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300919 · Cited by 74 · see citing works

Monoamine oxidase A variant influences antidepressant treatment response in female patients with Major Depression

Domschke, K., Hohoff, C., Mortensen, L. S., Roehrs, T., Deckert, J., Arolt, V., & Baune, B. T. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.011 · Cited by 69 · see citing works

The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients

Suzuki, Y., Sawamura, K., & Someya, T. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500256 · Cited by 54 · see citing works

Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder

Kang, R.-H., Wong, M., Choi, M.-J., Paik, J., & Lee, M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.05.018 · Cited by 47 · see citing works

Proteomics and the Human Metabolome Project

Wishart, D. S. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.3.333 · Cited by 45 · see citing works

Drug profiling by computed electroencephalography and brain maps, with special consideration of sertraline and its psychometric effects.

Saletu, B., & Grünberger, J. (1988) · PubMed · Cited by 42 · see citing works

Pharmaco-EEG Profile of Maroxepine:

Herrmann, W., Schärer, E., Wendt, G., & Delini‐Stula, A. (1991) · Pharmacopsychiatry · doi:10.1055/s-2007-1014471 · Cited by 18 · see citing works

The molecular neurobiology of depression

Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · see citing works

Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression

David, D. J., Samuels, B. A., Rainer, Q., Wang, J.-W., Marsteller, D., Mendez, I., Drew, M., Craig, D. A., Guiard, B. P., Guilloux, J.-P., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.04.017 · Cited by 1,267 · see citing works

Time for united action on depression: a Lancet–World Psychiatric Association Commission

Herrman, H., Patel, V., Kieling, C., Berk, M., Buchweitz, C., Cuijpers, P., Furukawa, T. A., Kessler, R. C., Kohrt, B. A., Maj, M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02141-3 · Cited by 1,104 · see citing works

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723 · see citing works

The neurobiology of depression and antidepressant action

Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519 · see citing works

Stress Hormone Regulation: Biological Role and Translation into Therapy

Holsboer, F., & Ising, M. (2010) · Annual Review of Psychology · doi:10.1146/annurev.psych.093008.100321 · Cited by 473 · see citing works

Unraveling the Time Domains of Corticosteroid Hormone Influences on Brain Activity: Rapid, Slow, and Chronic Modes

Joëls, M., Sarabdjitsingh, R. A., & Karst, H. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005892 · Cited by 425 · see citing works

Neuroimaging-aided differential diagnosis of the depressive state

Takizawa, R., Fukuda, M., Kawasaki, S., Kasai, K., Mimura, M., Pu, S., Noda, T., Niwa, S.-I., & Okazaki, Y. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.05.126 · Cited by 337 · see citing works

A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression

Ising, M., Lucae, S., Binder, E. B., Bettecken, T., Uhr, M., Ripke, S., Kohli, M. A., Hennings, J. M., Horstmann, S., Kloiber, S. M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.95 · Cited by 306 · see citing works

Wake and sleep EEG provide biomarkers in depression

Steiger, A., & Kimura, M. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.08.013 · Cited by 302 · see citing works

Heterogeneity of DSM-IV Major Depressive Disorder as a Consequence of Subthreshold Bipolarity

Zimmermann, P., Brückl, T. M., Nocon, A., Pfister, H., Lieb, R., Wïttchen, H., Holsboer, F., & Angst, J. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.158 · Cited by 264 · see citing works

Is the HPA Axis as Target for Depression Outdated, or Is There a New Hope?

Menke, A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00101 · Cited by 240 · see citing works

Adult Neurogenesis, Mental Health, and Mental Illness: Hope or Hype?: Figure 1.

Eisch, A. J., Cameron, H. A., Encinas, J. M., Meltzer, L. A., Ming, G., & Overstreet‐Wadiche, L. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3798-08.2008 · Cited by 247 · see citing works

Animal models for depression and the mismatch hypothesis of disease

Schmidt, M. V. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.07.001 · Cited by 204 · see citing works

Using Polymorphisms in FKBP5 to Define Biologically Distinct Subtypes of Posttraumatic Stress Disorder: Evidence From Endocrine and Gene Expression Studies

Mehta, D. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.50 · Cited by 200 · see citing works

Dual- and Triple-Acting Agents for Treating Core and Co-morbid Symptoms of Major Depression: Novel Concepts, New Drugs

Millan, M. J. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.10.039 · Cited by 197 · see citing works

Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?

Griebel, G., & Holsboer, F. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3702 · Cited by 194 · see citing works

Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial

Pizzagalli, D. A., Webb, C. A., Dillon, D. G., Tenke, C. E., Kayser, J., Goer, F., Fava, M., McGrath, P., Weissman, M., Parsey, R., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0252 · Cited by 189 · see citing works

Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment

Horstmann, S., Lucae, S., Menke, A., Hennings, J. M., Ising, M., Roeske, D., Müller-Myhsok, B., Holsboer, F., & Binder, E. B. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.180 · Cited by 185 · see citing works

Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients

Menke, A., Arloth, J., Pütz, B., Weber, P., Klengel, T., Mehta, D., Gonik, M., Rex-Haffner, M., Rubel, J., Uhr, M., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.331 · Cited by 177 · see citing works

Neurotransmitters excreted in the urine as biomarkers of nervous system activity: Validity and clinical applicability

Marc, D. T., Ailts, J. W., Campeau, D. A., Bull, M. J., & Olson, K. L. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.07.007 · Cited by 164 · see citing works

The double edged sword of neural plasticity: increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover

Branchi, I. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.08.011 · Cited by 156 · see citing works

Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks

Sarapas, C., Cai, G., Bierer, L. M., Golier, J. A., Galea, S., Ising, M., Rein, T., Schmeidler, J., Müller-Myhsok, B., Uhr, M., et al. (2011) · Disease Markers · doi:10.1155/2011/328054 · Cited by 143 · see citing works

Glucocorticoid signaling and stress-related limbic susceptibility pathway: About receptors, transcription machinery and microRNA

de Kloet, E. R., Fitzsimons, C. P., Datson, N. A., Meijer, O. C., & Vreugdenhil, E. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.039 · Cited by 139 · see citing works

Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas

Lanzenberger, R., Kranz, G. S., Haeusler, D., Akimova, E., Savli, M., Hahn, A., Mitterhauser, M., Spindelegger, C., Philippe, C., Fink, M., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.07.023 · Cited by 139 · see citing works

Immune changes and neurotransmitters: Possible interactions in depression?

Sperner‐Unterweger, B., Kohl, C. A., & Fuchs, D. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.006 · Cited by 134 · see citing works

Chronic fluoxetine treatment induces structural plasticity and selective changes in glutamate receptor subunits in the rat cerebral cortex

Ampuero, E., Rubio, F. J., Falcon, R., Sandoval, M., Diaz-Veliz, G., Gonzalez, R. E., Earle, N., Dagnino-Subiabre, A., Aboitiz, F., Orrego, F., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.035 · Cited by 132 · see citing works

Acid peptic diseases: pharmacological approach to treatment

Mejia, A. V., & Kraft, W. K. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.09.8 · Cited by 129 · see citing works

Pharmacogenomics of antidepressant drugs.

Horstmann, S., & Binder, E. (2009) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2009.06.007 · Cited by 120 · see citing works

Antidepressant Response and the Serotonin Transporter Gene-Linked Polymorphic Region

Taylor, M. J., Sen, S., & Bhagwagar, Z. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.034 · Cited by 118 · see citing works

Pharmacogenetics of antidepressants

Crisafulli, C., Fabbri, C., Porcelli, S., Drago, A., Spina, E., De Ronchi, D., & Serretti, A. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00006 · Cited by 113 · see citing works

Stress and Depression: Preclinical Research and Clinical Implications

Bartolomucci, A., & Leopardi, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004265 · Cited by 111 · see citing works

Implications of the Functional Integration of Adult-Born Hippocampal Neurons in Anxiety-Depression Disorders

David, D. J. P., Wang, J., Samuels, B. A., Rainer, Q., Mendez‐David, I., Gardier, A. M., & Hen, R. (2010) · The Neuroscientist · doi:10.1177/1073858409360281 · Cited by 107 · see citing works

Biomarkers in psychiatry: drawbacks and potential for misuse

Lakhan, S. E., Vieira, K. F., & Hamlat, E. J. (2010) · International Archives of Medicine · doi:10.1186/1755-7682-3-1 · Cited by 107 · see citing works

Mammalian Su(var) Genes in Chromatin Control

Fodor, B. D., Shukeir, N., Reuter, G., & Jenuwein, T. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113225 · Cited by 105 · see citing works

The prospect of FKBP51 as a drug target

Schmidt, M. V., Paez‐Pereda, M., Holsboer, F., & Hausch, F. (2012) · ChemMedChem · doi:10.1002/cmdc.201200137 · Cited by 99 · see citing works

Rhythmicity in mice selected for extremes in stress reactivity: behavioural, endocrine and sleep changes resembling endophenotypes of major depression

Touma, C., Fenzl, T., Ruschel, J., Palme, R., Holsboer, F., Kimura, M., & Landgraf, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004325 · Cited by 77 · see citing works

Nanosensors for Early Cancer Detection and for Therapeutic Drug Monitoring

Salvati, E., Stellacci, F., & Krol, S. (2015) · Nanomedicine · doi:10.2217/nnm.15.180 · Cited by 77 · see citing works

Dreaming under antidepressants: a systematic review on evidence in depressive patients and healthy volunteers

Tribl, G. G., Wetter, T. C., & Schredl, M. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.05.001 · Cited by 76 · see citing works

A pilot exploration of multi-omics research of gut microbiome in major depressive disorders

Zhao, H., Jin, K., Jiang, C., Pan, F., Wu, J., Luan, H., Zhao, Z., Chen, J., Mou, T., Wang, Z., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-021-01769-x · Cited by 74 · see citing works

Biomarkers Predicting Antidepressant Treatment Response: How Can We Advance the Field?

Labermaier, C., Masana, M., & Müller, M. B. (2013) · Disease Markers · doi:10.1155/2013/984845 · Cited by 76 · see citing works

Psychiatric patient stratification using biosignatures based on cerebrospinal fluid protein expression clusters

Maccarrone, G., Ditzen, C., Yassouridis, A., Rewerts, C., Uhr, M., Uhlén, M., Holsboer, F., & Turck, C. W. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.07.021 · Cited by 68 · see citing works

The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: A pilot study

Tadić, A., Wagner, S., Schlicht, K. F., Peetz, D., Borysenko, L., Dreimüller, N., Hiemke, C., & Lieb, K. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.011 · Cited by 71 · see citing works

Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression

James, G. M., Baldinger, P., Philippe, C., Kranz, G. S., Vanicek, T., Hahn, A., Gryglewski, G., Hienert, M., Spies, M., Traub‐Weidinger, T., et al. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00048 · Cited by 69 · see citing works

The role of pharmacogenetics in the treatment of depression and anxiety disorders

Schosser, A., & Kasper, S. F. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283306a2f · Cited by 67 · see citing works

How to measure glucocorticoid receptor’s sensitivity in patients with stress-related psychiatric disorders

Leistner, C., & Menke, A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.01.023 · Cited by 69 · see citing works

ABCB1 gene variants and antidepressant treatment outcome: A meta‐analysis

Breitenstein, B., Brückl, T. M., Ising, M., Müller‐Myhsok, B., Holsboer, F., & Czamara, D. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32309 · Cited by 66 · see citing works

The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study

Breitenstein, B., Scheuer, S., Pfister, H., Uhr, M., Lucae, S., Holsboer, F., Ising, M., & Brückl, T. M. (2013) · CNS Spectrums · doi:10.1017/s1092852913000436 · Cited by 66 · see citing works

Pharmacogenetics of antidepressant response

Keers, R., & Aitchison, K. J. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.186 · Cited by 66 · see citing works

Serotonergic and Noradrenergic Modulation of Emotion Processing by Single Dose Antidepressants

Brühl, A. B., Kaffenberger, T., & Herwig, U. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.159 · Cited by 64 · see citing works

CRH Signaling

Refojo, D., & Holsboer, F. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04983.x · Cited by 64 · see citing works

Neuroscience-driven discovery and development of sleep therapeutics

Dresler, M., Spoormaker, V. I., Beitinger, P., Czisch, M., Kimura, M., Steiger, A., & Holsboer, F. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.012 · Cited by 63 · see citing works

Brain, networks, depression, and more

Leistedt, S., & Linkowski, P. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.10.011 · Cited by 62 · see citing works

Epigenomics of Major Depressive Disorders and Schizophrenia: Early Life Decides

Hoffmann, A., Sportelli, V., Ziller, M. J., & Spengler, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081711 · Cited by 61 · see citing works

Prediction of antidepressant treatment response from gray matter volume across diagnostic categories

Sämann, P. G., Höhn, D., Chechko, N., Kloiber, S., Lucae, S., Ising, M., Holsboer, F., & Czisch, M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.07.004 · Cited by 55 · see citing works

Understanding posttraumatic stress disorder: insights from the methylome

Malan‐Müller, S., Seedat, S., & Hemmings, S. M. J. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12102 · Cited by 51 · see citing works

The MAKE Biomarker Discovery for Enhancing anTidepressant Treatment Effect and Response Study: Design and Methodology

Kang, H., Kim, J., Kim, S. Y., Kim, S., Shin, H., Shin, M., & Kim, J. (2018) · Psychiatry Investigation · doi:10.30773/pi.2017.10.2 · Cited by 50 · see citing works

The influence of psychiatric screening in healthy populations selection: a new study and meta-analysis of functional 5-HTTLPR and rs25531 polymorphisms and anxiety-related personality traits

Minelli, A., Bonvicini, C., Scassellati, C., Sartori, R., & Gennarelli, M. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-50 · Cited by 49 · see citing works

Pharmacogenetics of anxiolytic drugs

Tiwari, A. K., de Souza, R. P., & Müller, D. J. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0229-6 · Cited by 47 · see citing works

Gabapentin-Induced Delirium and Dependence

Kruszewski, S. P., Paczynski, R. P., & Kahn, D. A. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000358318.73684.df · Cited by 47 · see citing works

Targeting Glia Cells: Novel Perspectives for the Treatment of Neuropsychiatric Diseases

Benedetto, B. D., & Rupprecht, R. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311020004 · Cited by 46 · see citing works

Serotonin transporter gene polymorphism and psychiatric disorders: Is there a link?

Margoob, M., & Mushtaq, D. (2011) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.91901 · Cited by 47 · see citing works

Serotonin transporter gene polymorphisms and treatment-resistant depression

Bonvicini, C., Minelli, A., Scassellati, C., Bortolomasi, M., Segala, M., Sartori, R., Giacopuzzi, M., & Gennarelli, M. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.020 · Cited by 45 · see citing works

Epigenetic Biomarkers of Preterm Birth and Its Risk Factors

Knight, A. K., & Smith, A. K. (2016) · Genes · doi:10.3390/genes7040015 · Cited by 45 · see citing works

Precision pharmacotherapy: psychiatry’s future direction in preventing, diagnosing, and treating mental disorders

Menke, A. (2018) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s146110 · Cited by 41 · see citing works

Antistress properties of antidepressant drugs and their clinical implications

Calabrese, F., Molteni, R., & Riva, M. A. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.05.007 · Cited by 41 · see citing works

The Mechanisms Underlying Autonomous Adrenocorticotropic Hormone Secretion in Cushing’s Disease

Fukuoka, H., Shichi, H., Yamamoto, M., & Takahashi, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239132 · Cited by 39 · see citing works

Acute administration of fluoxetine normalizes rapid eye movement sleep abnormality, but not depressive behaviors in olfactory bulbectomized rats

Wang, Y., Tu, Z., Xu, X., Li, R., Qu, W., Urade, Y., & Huang, Z. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07558.x · Cited by 38 · see citing works

Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression

Kloiber, S. M., Kohli, M. A., Brueckl, T., Ripke, S., Ising, M., Uhr, M., Menke, A., Unschuld, P. G., Horstmann, S., Salyakina, D., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.142 · Cited by 37 · see citing works

Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations

Möller, H., & Maier, W. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0070-9 · Cited by 36 · see citing works

Dasatinib, imatinib and staurosporine capture compounds — Complementary tools for the profiling of kinases by Capture Compound Mass Spectrometry (CCMS)

Fischer, J. J., Dalhoff, C., Schrey, A. K., Graebner, O. Y., Michaelis, S., Andrich, K., Glinski, M., Kroll, F. K., Sefkow, M., Dreger, M., et al. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.05.035 · Cited by 36 · see citing works

Effect of Damaging Rare Mutations in Synapse-Related Gene Sets on Response to Short-term Antipsychotic Medication in Chinese Patients With Schizophrenia

Wang, Q., Wu, H. M., Yue, W., Yan, H., Zhang, Y., Tan, L., Deng, W., Chen, Q., Yang, G., Lu, T., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3039 · Cited by 36 · see citing works

Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials

Noma, H., Furukawa, T. A., Maruo, K., Imai, H., Shinohara, K., Tanaka, S., Ikeda, K., Yamawaki, S., & Cipriani, A. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.03.031 · Cited by 36 · see citing works

Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests

Menke, A., Arloth, J., Best, J., Namendorf, C., Gerlach, T., Czamara, D., Lucae, S., Dunlop, B. W., Crowe, T. M., Garlow, S. J., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.04.003 · Cited by 35 · see citing works

The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder

Lee, S.-Y., Chen, S.-L., Chang, Y.-H., Chen, S.-H., Chu, C.-H., Huang, S.-Y., Tzeng, N.-S., Wang, C.-L., Lee, I. H., Yeh, T. L., et al. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.01.024 · Cited by 35 · see citing works

Probing prefrontal cortex hemodynamic alterations during facial emotion recognition for major depression disorder through functional near-infrared spectroscopy

Gao, L., Cai, Y., Wang, H., Wang, G., Zhang, Q., & Yan, X. (2019) · Journal of Neural Engineering · doi:10.1088/1741-2552/ab0093 · Cited by 34 · see citing works

Stress-related depression: Neuroendocrine, genetic, and therapeutical aspects

Bosch, O., Seifritz, E., & Wetter, T. C. (2012) · World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.665477 · Cited by 36 · see citing works

Gene × environment interactions in the prediction of response to antidepressant treatment

Klengel, T., & Binder, E. B. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001459 · Cited by 34 · see citing works

General overview

Filiou, M. D., & Turck, C. W. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-387718-5.00001-8 · Cited by 34 · see citing works

Algorithm-guided treatment of depression reduces treatment costs — Results from the randomized controlled German Algorithm Project (GAPII)

Ricken, R., Wiethoff, K., Reinhold, T., Schietsch, K., Stamm, T. J., Kiermeir, J., Neu, P., Heinz, A., Bauer, M., & Adli, M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.05.053 · Cited by 33 · see citing works

Glucocorticoids as Predictors of Treatment Response in Depression

Horstmann, S., & Binder, E. B. (2011) · Harvard Review of Psychiatry · doi:10.3109/10673229.2011.586550 · Cited by 30 · see citing works

ccSVM: correcting Support Vector Machines for confounding factors in biological data classification

Li, L., Rakitsch, B., & Borgwardt, K. M. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr204 · Cited by 33 · see citing works

Serotonin transporter clustering in blood lymphocytes as a putative biomarker of therapeutic efficacy in major depressive disorder

Baltanás, T. R., Olivares, J. M., Calado-Otero, M., Kalynchuk, L. E., Martinez-Villamarin, J. R., & Caruncho, H. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.041 · Cited by 32 · see citing works

Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression

Tammiste, A., Jiang, T., Fischer, K., Mägi, R., Krjutškov, K., Pettai, K., Esko, T., Li, Y., Tansey, K. E., Carroll, L., et al. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113499829 · Cited by 31 · see citing works

Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder

Tadić, A., Wagner, S., Gorbulev, S., Dahmen, N., Hiemke, C., Braus, D. F., & Lieb, K. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-16 · Cited by 31 · see citing works

Neuropathology of Kynurenine Pathway of Tryptophan Metabolism

Tutakhail, A., Boulet, L., Khabil, S., Nazari, Q., Hamid, H., & Coudoré, F. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-019-00208-2 · Cited by 28 · see citing works

Personalized Medicine in Neurodegenerative Diseases: How Far Away?

Gotovac, K., Hajnšek, S., Pašić, M. B., Pivac, N., & Borovečki, F. (2013) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-013-0058-z · Cited by 28 · see citing works

Are personalised treatments of adult depression finally within reach?

Cuijpers, P. J., & Christensen, H. M. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s204579601600007x · Cited by 28 · see citing works

Circuit-targeted modulation of anxiety symptoms in individuals with major depression: A randomized head-to-head TMS trial

Taylor, J. J., Li, J., Lin, C., Jones, E., Frandsen, S. B., Becker, C. R., Drew, W., Haj-Darwish, D., Jabbour, S., Leach, J., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03535-1 · Cited by 26 · see citing works

Is there a personalized medicine for mood disorders?

Bartova, L., Berger, A., & Pezawas, L. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0152-8 · Cited by 26 · see citing works

Gene expression: Biomarker of antidepressant therapy?

Menke, A. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.825580 · Cited by 25 · see citing works

Epistasis detection on quantitative phenotypes by exhaustive enumeration using GPUs

Kam-Thong, T., Pütz, B., Mirza‐Schreiber, N., Müller‐Myhsok, B., & Borgwardt, K. M. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr218 · Cited by 25 · see citing works

Individual response to antidepressants for depression in adults-a meta-analysis and simulation study

Munkholm, K., Homan, S., & Homan, P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237950 · Cited by 23 · see citing works

From vasotocin to stress and cognition

de Kloet, E. R. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.017 · Cited by 22 · see citing works

The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk—a European multicentre study on treatment-resistant major depressive disorder

Höfer, P., Schosser, A., Calati, R., Serretti, A., Massat, I., Kocabaş, N. A., Konstantinidis, A., Linotte, S., Mendlewicz, J., Souery, D., et al. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0375-y · Cited by 22 · see citing works

Integrative Biological Analysis For Neuropsychopharmacology

Emmett, M. R., Kroes, R. A., Moskal, J. R., Conrad, C. A., Priebe, W., Laezza, F., Meyer‐Baese, A., & Nilsson, C. L. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.156 · Cited by 20 · see citing works

Cordance derived from REM sleep EEG as a biomarker for treatment response in depression – a naturalistic study after antidepressant medication

Adamczyk, M., Gazea, M., Wollweber, B., Holsboer, F., Dresler, M., Steiger, A., & Pawlowski, M. A. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.02.007 · Cited by 20 · see citing works

Targeted exome sequencing identifies five novel loci at genome-wide significance for modulating antidepressant response in patients with major depressive disorder

Xu, Z., Xie, C., Xia, L., Yuan, Y., Zhu, H., Huang, X., Li, C., Yu, T., Qu, X., Zhang, F., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0689-x · Cited by 19 · see citing works

Hypothalamic stress systems in mood disorders

(2021) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-819973-2.00003-4 · Cited by 15 · see citing works

Intraday Activity Levels May Better Reflect the Differences Between Major Depressive Disorder and Bipolar Disorder Than Average Daily Activity Levels

Tanaka, T., Kumiko, K., Iwasa, K., Sawa, K., Yamada, N., & Komori, M. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.02314 · Cited by 15 · see citing works

Pharmacogenetics – genomics and personalized psychiatry

Möller, H. ‐., & Rujescu, D. (2010) · European Psychiatry · doi:10.1016/j.eurpsy.2009.12.015 · Cited by 14 · see citing works

Personalized Pharmacotherapy: A Historical Perspective on the Pharmacogenomics of Depression

Perry, S. W., Licinio, J., & Wong, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00204-8

Prospects for personalization of depression treatment with genome sequencing

Borczyk, M., Piechota, M., Parkitna, J. M. R., & Korostyński, M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15470 · Cited by 6 · see citing works

Role of CYP2D6 Gene Variants and Family History in Personalized Antidepressant Treatments for Depression

Minji, K. O., Yumin, K. I. M., Ho-Keun, C. H. O. I., & Ho-Keun, C. H. O. I. (2025) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2025.57.1.16

Pharmacogenetics of antidepressant response

Porcelli, S., Drago, A., Fabbri, C., Gibiino, S., Calati, R., & Serretti, A. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100059 · Cited by 179 · see citing works